For the fiscal fourth quarter ended March 31, 2025, net sales are estimated to range from $51.1 million to $53.1 million compared to $66.5 million in the prior year period. Net loss is estimated to range from $9.9 million to $10.4 million compared to a net loss of $5.0 million in the prior year period. Net loss includes the tax expense impact of recording a valuation allowance on the Company’s net deferred tax assets of $6.4 million.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PETS:
- Options Volatility and Implied Earnings Moves Today, June 16, 2025
- Options Volatility and Implied Earnings Moves This Week, June 16 – June 20, 2025
- Options Volatility and Implied Earnings Moves Today, June 10, 2025
- Options Volatility and Implied Earnings Moves This Week, June 09 – June 12, 2025
- Petmed Express (PETS) Q4 Earnings Cheat Sheet